RIFAMATE RIFAMATE (Rifamate 150 mg / 300 mg)
Generic Name: isoniazid/rifampin
Pill with imprint RIFAMATE RIFAMATE is Red, Capsule-shape and has been identified as Rifamate 150 mg / 300 mg. It is supplied by Aventis Pharmaceuticals.
Rifamate is used in the treatment of tuberculosis, active and belongs to the drug class antituberculosis combinations. FDA has not classified the drug for risk during pregnancy. Rifamate 150 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RIFAMATE RIFAMATE
Rifamate
- Generic Name
- isoniazid/rifampin
- Imprint
- RIFAMATE RIFAMATE
- Strength
- 150 mg / 300 mg
- Color
- Red
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antituberculosis combinations
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aventis Pharmaceuticals
- National Drug Code (NDC)
- 00068-0509 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
FD&C Blue No. 1,
FD&C Red No. 40,
magnesium stearate,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
More about Rifamate (isoniazid / rifampin)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Drug images
- En español
- Drug class: antituberculosis combinations
Patient resources
- Other brands
- IsonaRif
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.